Skip to main content

Table 2 Baseline patients’ characteristics

From: Evaluation of long-term changes of aspartate—platelet ratio index, FIB4, and liver stiffness in chronic hepatitis C patients successfully treated by direct-acting antivirals

Age (years)

48 ±15

BMI

26 ±3.7

Female (%)

48

Male (%)

52

Diabetes (%)

14

Hypertension (%)

12

Other co-morbidities*(%)

11

HCV RNA quantitative*

2066.45±4000

ALT (IU/L)

53.5±40

AST (IU/L)

48±29

AFP (IU/L)

4.3±3.4

Albumin (g/dL)

4.1±0.5

Total bilirubin (mg/dL)

0.75±0.4

Indirect bilirubin (mg/dL)

0.48±0.4

WBCx103/mm3

7.1±2.2

Hb (g/dL)

13.5±1.8

Creatinine (mg/dL)

0.9±0.2

INR

1.1±0.1

Platelets×103/mm3

231.7±72

Fibrosis stage (F) by TE (%)

F0 (23%)

F1 (26%)

F2 (14 %)

F3 (9%)

F4 (28%)

  1. *Ischemic heart diseases and bronchial asthma